NASDAQ · Specialty Chemicals · USD
Bon Natural Life Limited (BON) Stock Analysis
Bon Natural Life Limited (BON) is a Specialty Chemicals stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
BON Key Statistics
As of Oct 21, 2026Trading
- Open
- $1.10
- Previous Close
- $1.11
- Day's Range
- 1.08–1.16
- 52-Week Range
- 0.95–2.10
- Volume
- 24.41K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- −0.34
Valuation
- Market Cap
- $9.14M
- P/E Ratio
- unprofitable
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 1.93
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.49
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −2.79
Financials (FY)
- Revenue (FY)
- $18.67M−21.70%
- Net Income (FY)
- −$1.99M−600.98%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −60.39%
- Shares Outstanding
- 6.13M
- 1-Year Return
- −43.00%
Dividend and dates
- Avg Volume
- 8.75K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, BON closed at $1.14, −43.00% over 1 year.
Bon Natural Life Limited (BON) has a market capitalization of $9.14M.
In fiscal 2025, BON reported revenue of $18.67M.
BON Stock Return by Calendar Year
Bon Natural Life Limited (BON) return since Jun 2021: what $10,000 became
- 1 year
- $10,000 $5,700
- −43.00%
- 5 years
- $10,000 $6
- −99.94%
- Since Jun 2021
- $10,000 $6
- −99.94%
If you had invested $10,000 in Bon Natural Life Limited (BON) at the close on June 24, 2021, the earliest close on record here, it would have been worth $6 at the close on October 21, 2026: −99.94% in total, −74.92% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −28.30% |
| 2025 | −96.41% |
| 2024 | −67.22% |
| 2023 | −48.91% |
| 2022 | −76.25% |
| 2021 (partial year) | −38.19% |
As of October 21, 2026.
BON Revenue and Earnings by Fiscal Year
FY ends September| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $18.67M | −$1.99M | −10.7% |
| 2024 | $23.84M | $398.17K | 1.7% |
| 2023 | $29.52M | $4.60M | 15.6% |
| 2022 | $29.91M | $6.24M | 20.9% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $18.67M | $3.88M | −$1.59M | −$1.99M | −10.7% |
| 2024 | $23.84M | $7.11M | $1.94M | $398.17K | 1.7% |
| 2023 | $29.52M | $8.84M | $5.96M | $4.60M | 15.6% |
| 2022 | $29.91M | $9.42M | $7.91M | $6.24M | 20.9% |
Annual figures as reported, in the company's reporting currency. As of September 30, 2025.
BON Valuation vs Specialty Chemicals Median
Median of 70 stocks| Metric | BON | Specialty Chemicals median | vs median |
|---|---|---|---|
| P/S ratio | 0.49 | 1.59 | 0.3x the median |
| Profit margin | −60.39% | 2.70% | 63.1 pts below |
Medians across 70 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Specialty Chemicals Stocks
Linde plc
$230.75B
SHWThe Sherwin-Williams Company
$81.88B
ECLEcolab Inc.
$80.76B
APDAir Products and Chemicals, Inc.
$67.40B
PPGPPG Industries, Inc.
$24.49B
IFFInternational Flavors & Fragrances Inc.
$23.23B
Popular Basic Materials Stocks
BHP Group Limited
$211.50B
SCCOSouthern Copper Corporation
$167.24B
RIORio Tinto Group
$141.37B
NEMNewmont Corporation
$123.47B
FCXFreeport-McMoRan Inc.
$98.94B